A second comparison (hormone-sensitive vs. castration-resistant PCa) yielded 426 DEGs; lipid-metabolic circuits (arachidonic-acid, PPAR, AMPK) dominated, with SCD and FASN emerging as progression-specific targets. The gene discussed is FASN; the disease is posterior cortical atrophy.